Suchergebnisse - "Wuerstlein, Rachel"

PubPharm (35)

1

Lessons learned: the first consecutive 1000 patients of the $ CCCMunich^{LMU} $ Molecular Tumor Board

enthalten in: Journal of cancer research and clinical oncology | 2022

von Heinrich, K. | Miller-Phillips, L. | Ziemann, F. | +26

2

Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany

enthalten in: Archives of gynecology and obstetrics | 2021

von Kaltofen, T. | Hagemann, F. | Harbeck, N. | +5

3

NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU

enthalten in: Archives of gynecology and obstetrics | 2020

von Sultova, E. | Westphalen, C. | Jung, A. | +13

4

CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib

enthalten in: Clinical immunotherapeutics | 2019

von Eggersmann, T. | Degenhardt, T. | Gluz, O. | +2

5

Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial

enthalten in: Breast cancer research and treatment | 2019

von Nitz, U. | Gluz, O. | Christgen, M. | +18

6

Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer

enthalten in: Breast cancer research and treatment | 2019

von Wunderle, M. | Pretscher, J. | Brucker, S. | +47

7

Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational study

enthalten in: Strahlentherapie und Onkologie | 2018

von Rogowski, P. | Schönecker, S. | Pazos, M. | +9

8

Evaluation of an interdisciplinary palliative care inhouse training for professionals in gynecological oncology

enthalten in: Archives of gynecology and obstetrics | 2018

von Kolben, T. | Haberland, B. | Degenhardt, T. | +8

9

Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial

enthalten in: Breast cancer research and treatment | 2017

von Nitz, U. | Gluz, O. | Christgen, M. | +18

10

Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer

enthalten in: Journal of cancer research and clinical oncology | 2017

von Vattai, A. | Akyol, E. | Kuhn, C. | +12